Condition
Akathisia, Drug-Induced
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
66.7%
2 terminated out of 3 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
2 of 0 completed with results
Key Signals
2 with results0
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Terminated2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07715994Not Yet Recruiting
A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms
NCT00686699Phase 2TerminatedPrimary
Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
NCT00693472Phase 2TerminatedPrimary
Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
Showing all 3 trials